Evidence map›Paper›PMID 31217729›Full record

ArticleInternational journal of medical sciences2019

Chengwen Teng, Kelly R Reveles, Obiageri O Obodozie-Ofoegbu, Christopher R Frei

Abstract read
In one paragraph

Article in International journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Initial empiric carbapenem versus non-carbapenem β-lactam/β-lactamase inhibitor therapy in sepsis across simplified SENECA phenotypes: a retrospective study of two independent cohorts.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Review
  3. Clinical Characteristics and Risk Factors ofJournal of clinical medicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Derivation and validation of a prediction model for primary and recurrentAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Ultrasound-Mediated Antibiotic Delivery to In Vivo Biofilm Infections: A Review.Chembiochem : a European journal of chemical biology · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. ImprovingAntibiotics (Basel, Switzerland) · 2024
    Article
  18. Vonoprazan-associatedTherapeutic advances in drug safety · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chengwen TengPharmacotherapy Division, College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA.
Kelly R RevelesPharmacotherapy Division, College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA.
Obiageri O Obodozie-OfoegbuPharmacotherapy Division, College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA.
Christopher R FreiPharmacotherapy Division, College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA.

Funding

Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR002645 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2018 to 2022
$20.4M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
San Antonio OAIC - Research Education Component (REC)P30AG044271 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Adam Salmon, Elena Volpi · 2015 to 2026
$14.1M
NRSA Training Core (TL1)TL1TR002647 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHUN, YONG-HEE PATRICIA, FREI, CHRISTOPHER R. · 2018 to 2022
$1.8M
NCATS NIH HHS TL1 TR002647NCATS NIH HHS UL1 TR001120NCATS NIH HHS UL1 TR002645NIA NIH HHS P30 AG044271
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAdverse Drug Reaction Reporting SystemsAgedAged, 80 and overAnti-Bacterial AgentsAntimicrobial StewardshipClostridium InfectionsFemaleHumansIncidenceLincosamidesMaleMiddle AgedRisk FactorsUnited StatesUnited States Food and Drug AdministrationAnti-Bacterial AgentsLincosamidesadverse drug eventsantibioticsantimicrobial stewardshipClostridium difficile

Identifiers

PMID31217729
PMCPMC6566741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.